Oobli
Oobli is a precision fermentation company producing nature-identical sweet proteins from West African fruits as sugar alternatives for food and beverage manufacturers. It operates a B2B ingredient platform, partnering with major CPG companies like Ingredion, Mars, and Grupo Bimbo.
- Company typePrivate
- Founded2016
- HeadquartersDavis, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Oobli does
Oobli is a Davis, California-based precision fermentation company that produces nature-identical sweet proteins (primarily brazzein, monellin, thaumatin, and miraculin) from rare West African fruits as sugar alternatives for the food and beverage industry. The company was founded around 2014-2016 by Dr. Jason Ryder and operates with 11-50 employees. Its core technology uses bioengineered yeast to express sweet proteins that are 1,000-5,000 times sweeter than sugar on a like-for-like basis, can replace 60-90% of sugar in finished products, and digest as protein with no impact on blood sugar, insulin, or gut microbiome. Oobli has secured three FDA "no questions" letters confirming GRAS status and holds FEMA GRAS status as a natural flavor.
The company operates a dual-mode business. On the B2B side, Oobli supplies sweet protein ingredients and formulation support to major CPG partners — including Ingredion (which also led its $18M Series B1), Mars, Grupo Bimbo, SIG Group, and Magdalena — and has demonstrated 50-100% sugar reduction across a prototype pantry of 14+ application formulations spanning beverages, dairy, baked goods, confections, and sports nutrition. On the consumer side, Oobli sells branded chocolate bars direct-to-consumer via oobli.com at $3.99-$21.99, but has explicitly de-emphasized consumer-facing product manufacturing in favor of partner-enabled reformulation.
Oobli generates revenue primarily through B2B ingredient licensing and royalty arrangements with CPG companies, supplemented by direct e-commerce sales of its chocolate products (Continental US shipping only). Its named customer base spans multiple industries — bakery (Grupo Bimbo), confectionery (Mars), ingredients (Ingredion), packaging/beverages (SIG Group), and LATAM sugar/production (Magdalena) — while its target end-consumer segments include health-conscious adults, GLP-1 medication users, sports nutrition consumers, and individuals managing blood sugar. The company is led by CEO Ali Wing, Founder/CTO Dr. Jason Ryder, and Founder/President Alan Perlstein, with a scientific advisory board anchored by Dr. Francine Kaufman and Dr. Chris Damman.
Oobli firmographics
Firmographics- Name
- Oobli
- Legal name
- Oobli, Inc.
- Website
- https://oobli.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Oobli is a precision fermentation company producing nature-identical sweet proteins from West African fruits as sugar alternatives for food and beverage manufacturers. It operates a B2B ingredient platform, partnering with major CPG companies like Ingredion, Mars, and Grupo Bimbo.
- Ownership category
- akta.pro rank
Oobli industry classification
Industry- Product category
- Sweet Protein Ingredients
- NAICS
- Sugar and Confectionery Product Manufacturing (3113), Flavoring Syrup and Concentrate Manufacturing (311930)
- SIC
- Sugar & Confectionery Products (2060), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin) (AFAJAAAH)
- akta.pro secondary industry
- Sweeteners (Sugar, HFCS, Alternative Sweeteners) (CRADAOAB)
Keywords
Where Oobli is headquartered
LocationHeadquarters
- HQ city
- Davis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Oobli business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Revenue model
- B2B Ingredient Sales: Oobli provides sweet protein ingredients to food and beverage companies for reformulation. The company partners with major CPG companies to integrate its technology into existing sweetener systems, positioning itself as a platform rather than a consumer brand.
- Direct-to-Consumer Chocolate Sales: Oobli sells chocolate bars directly through its e-commerce platform (oobli.com), including milk chocolate and dark chocolate varieties. The company previously produced consumer-facing products but has shifted focus to B2B partnerships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Milk Chocolate Variety Pack Minis (10-pack) |
| Unit Pricing | Pay-as-you-go | Dark Chocolate Variety Pack Minis (10-pack) |
| Unit Pricing | Pay-as-you-go | Chocolate Minis Trial Pack (4 pcs) |
| Unit Pricing | Pay-as-you-go | Milk Chocolate Variety Pack Bars (4-pack) |
| Subscription | Monthly | Subscription Discount |
| Unit Pricing | Pay-as-you-go | Dark Chocolate Sweet 'n Salty Bars |
| Unit Pricing | Pay-as-you-go | Oobli Water Bottle |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Oobli product offering
Product offeringCore offering
Oobli produces nature-identical sweet proteins (brazzein, monellin, thaumatin, miraculin) via precision fermentation using bioengineered yeast, supplying these as sugar-alternative ingredients to food and beverage manufacturers for product reformulation. The company also sells direct-to-consumer low-sugar dark and milk chocolate bars sweetened with its own sweet proteins as proof-of-concept consumer products. The sweet proteins are 1,000-5,000 times sweeter than sugar and can replace 60-90% of sugar in chocolate, dairy, baked goods, beverages, sauces, and frozen foods without affecting blood sugar or gut microbiome.
Product overview
Oobli operates as a dual-mode sweet protein company combining a B2B ingredient platform with consumer packaged goods. The core technology is precision-fermented sweet proteins (brazzein, monellin) derived from West African fruits that provide sugar-like sweetness while digesting as protein with no glycemic impact. The B2B platform provides these proteins as ingredients to major food companies (Ingredion, Mars, SIG, Grupo Bimbo) for reformulation across beverages, dairy, baked goods, and confections, with a prototype library demonstrating 50-100% sugar reduction across 12+ applications. The consumer side offers direct-to-consumer chocolate bars (dark and milk chocolate varieties) as proof-of-concept products demonstrating the technology's taste and health benefits, while the company has ceased direct consumer beverage production to focus on partner-enabled reformulation.
Differentiator
Problem solved
Functional benefit
Products and services
- Sweet Proteins (Brazzein Ingredient)
Quantifiable outcome
- Sugar reduction of 60-90% in food and beverage applications
- +4 more outcomes
Companies that use Oobli
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Oobli technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Oobli partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- MagdalenacoreAndean regional manufacturing partnership with Magdalena's new biochem unit. Magdalena is building precision fermentation capacity in Guatemala and will produce sweet proteins for Oobli, leveraging sugarcane feedstock and existing infrastructure to lower production costs.
- SIG GroupcoreStrategic partnership to develop reduced-sugar, protein-sweetened beverages using Oobli's sweet protein technology and SIG's aseptic packaging solutions. Collaboration aims to deliver shelf-stable, preservative-free beverages without refrigeration requirements.
- MarscoreMars is investing in and supporting the development of precision fermentation technologies for food ingredients including dairy proteins, sweeteners, and natural colors. Mars aims to help Oobli navigate regulatory challenges and scale-up issues while integrating sweet proteins into their product portfolio.
- Grupo BimbocoreLandmark partnership with the world's largest bakery brand to integrate Oobli's sweet proteins into Bimbo's beloved baked goods. Testing demonstrated 60-70% sugar reduction in baked goods without affecting taste or texture.
- IngredioncoreStrategic partnership to accelerate market access for Oobli's sweet proteins as sugar alternatives. The collaboration combines Oobli's sweet proteins with Ingredion's natural sweeteners portfolio, providing broader market reach and formulation expertise for CPG companies seeking sugar reduction solutions.
- MISTAminorFood innovation platform based in San Francisco where Oobli participates as an active member alongside major food corporations. The platform facilitates growth hack demo days and collaborations between startups and corporate partners.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Oobli competitors and assessment
Company assessmentDirect peers
- Amai Proteins: Israeli food-tech company producing sweet proteins via precision fermentation as sugar alternatives. Most direct competitor to Oobli in sweet-protein technology, though with a different geographic and partner footprint.
- SweeGen: Specialty sweetener company focused on stevia and monk-fruit-based sugar-reduction solutions for CPG customers. Direct B2B competitor in the natural sweetener space, though without the protein-based positioning.
Broad incumbents
- Tate & Lyle: Global B2B ingredient supplier offering sweetener systems including stevia, allulose, and sucralose. Comparable in targeting CPG reformulation but operates across a much broader specialty food ingredient portfolio.
- Ingredion: Major B2B sweetener and ingredient distributor that is simultaneously Oobli's lead investor and commercial partner. Serves the same CPG customers and offers competing stevia- and monk-fruit-based sweetener systems.
- Cargill: Global agricultural commodity and food ingredient giant with a broad sweetener portfolio (corn syrup, stevia, allulose). Competes with Oobli for CPG sugar-replacement programs and brings significant scale and supply-chain advantages.
Emerging players
- Bonumose: Early-stage producer of tagatose and other rare sugars via enzymatic conversion for sugar reduction. Competes with Oobli for CPG sugar-replacement mandates using a carbohydrate-based rather than protein-based approach.
- Perfect Day: Precision-fermentation company producing animal-free dairy proteins. Shares Oobli's fermentation technology platform and enterprise go-to-market model but addresses the dairy protein category rather than sweeteners.
- Conagen: Precision-fermentation CDMO and ingredient developer producing high-value biologics including sweeteners. Comparable technology platform with broader ingredient scope and contract-manufacturing capabilities.
- Geltor: Precision-fermentation company producing animal-free proteins for food and personal care. Similar fermentation technology stack and B2B ingredient model, though targeted at protein ingredients rather than sweetener functionality.
Others
- Amyris: Fermentation-derived ingredients company that pioneered sugar-cane-fed precision fermentation at scale for specialty ingredients. While now restructured, it established the technology and commercial template that Oobli's Magdalena partnership echoes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Oobli social profiles
Digital presenceOobli compliance and trust
Trust signalCompliance2 records
Oobli financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oobli leadership team
Management profileNumber of profiles
Profiles7 records
Oobli funding detail
Funding detailFunding overview
Funding rounds7 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oobli M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oobli
What does Oobli do?
Oobli produces nature-identical sweet proteins (brazzein, monellin, thaumatin, miraculin) via precision fermentation using bioengineered yeast, supplying these as sugar-alternative ingredients to food and beverage manufacturers for product reformulation. The company also sells direct-to-consumer low-sugar dark and milk chocolate bars sweetened with its own sweet proteins as proof-of-concept consumer products. The sweet proteins are 1,000-5,000 times sweeter than sugar and can replace 60-90% of sugar in chocolate, dairy, baked goods, beverages, sauces, and frozen foods without affecting blood sugar or gut microbiome.
Is Oobli a public or private company?
Oobli is a private company. It is classified as venture growth investor backed and is currently operating.
When was Oobli founded?
Oobli was founded in 2016. It employs 11 to 50 people.
Where is Oobli based?
Oobli is headquartered in Davis, United States, in the North America region.
How does Oobli make money?
Two revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are direct-to-Consumer Chocolate Sales.
Who are Oobli's main competitors?
Direct peers on record are Amai Proteins and SweeGen. Broad incumbents are Tate & Lyle, Ingredion and Cargill. Emerging players are Bonumose, Perfect Day, Conagen and Geltor. Amyris is listed as an others.
Does Oobli have an API?
No public API is recorded for Oobli.
What industry is Oobli in?
Oobli's product category is Sweet Protein Ingredients. Its primary akta.pro industry code is AFAJAAAH, Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin), with a secondary code of CRADAOAB, Sweeteners (Sugar, HFCS, Alternative Sweeteners). Its NAICS code is 3113 and its SIC code is 2060.